Mirum Pharmaceuticals (MIRM) Total Liabilities (2018 - 2026)

Mirum Pharmaceuticals' Total Liabilities history runs 9 years deep, the most recent figure standing at $648.4 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 41.89% year-over-year to $648.4 million; the TTM figure through Mar 2026 stood at $648.4 million (up 41.89% YoY), while the FY2025 annual figure was $528.1 million, up 18.65% from the prior year.
• Total Liabilities for Q1 2026 stood at $648.4 million, up from $528.1 million in the prior quarter.
• The five-year high for Total Liabilities was $648.4 million in Q1 2026, with the low at $169.2 million in Q1 2022.
• The 5-year median for Total Liabilities is $417.4 million (2024), against an average of $378.0 million.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities jumped 116.95% in 2024, then rose 9.01% in 2025.
• Mirum Pharmaceuticals' Total Liabilities stood at $210.9 million in 2022, then jumped by 88.72% to $398.0 million in 2023, then grew by 11.85% to $445.1 million in 2024, then climbed by 18.65% to $528.1 million in 2025, then climbed by 22.78% to $648.4 million in 2026.
• Business Quant data shows MIRM's Total Liabilities at $648.4 million in Q1 2026, $528.1 million in Q4 2025, and $493.1 million in Q3 2025.